Literature DB >> 2691929

Neuroendocrine aspects of the serotonergic hypothesis of depression.

L D Van de Kar1.   

Abstract

This review examines the role of serotonin (5-HT) in depression. Dysfunction of serotonergic neurons has been implicated as one of the causes of endogenous depression. Since serotonergic neurons innervate the hypothalamus and these neurons send collaterals to several other brain areas, it is possible that hypothalamic sites which control hormone secretion receive the same serotonergic afferents that innervate other limbic areas in the brain. Several investigators have devised neuroendocrine challenge tests measuring the effect of 5-HT agonists on plasma cortisol and prolactin in depressed patients. These tests help to identify dysfunctional 5-HT neurons, and are a "window into the brain." The secretion of cortisol and prolactin is increased predominantly by 5-HT1 receptors. However, changes in 5-HT2 receptors have also been implicated in depression. Results from our laboratory and by others suggest that brain serotonergic neurons stimulate renin and vasopressin secretion by activation of 5-HT2 receptors. Therefore, the renin and vasopressin response to 5-HT agonists should be included in neuroendocrine tests of serotonergic function in affective disorders. Since antidepressants produce a decrease in the density of 5-HT2 receptors, renin and vasopressin could be used to evaluate the antidepressant potential of new drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2691929     DOI: 10.1016/s0149-7634(89)80056-9

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  8 in total

Review 1.  The 5-HT receptor--G-protein--effector system complex in depression. I. Effect of glucocorticoids.

Authors:  K P Lesch; B Lerer
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Ovarian steroid action on tryptophan hydroxylase protein and serotonin compared to localization of ovarian steroid receptors in midbrain of guinea pigs.

Authors:  N Z Lu; T A Shlaes; C Gundlah; S E Dziennis; R E Lyle; C L Bethea
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

3.  Sex differences in corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity.

Authors:  Alexis R Howerton; Alison V Roland; Jessica M Fluharty; Anikò Marshall; Alon Chen; Derek Daniels; Sheryl G Beck; Tracy L Bale
Journal:  Biol Psychiatry       Date:  2013-10-23       Impact factor: 13.382

4.  Neuroendocrine effects of ipsapirone on the hypothalamic-pituitary adrenal axis: CRF, ACTH and cortisol in healthy volunteers.

Authors:  M Beneke; W Wingender; R Horstmann; I Konrad-Dalhoff; H Weber; J Kuhlmann; B H Schmidt
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques.

Authors:  M Pecins-Thompson; N A Brown; S G Kohama; C L Bethea
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

6.  Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin.

Authors:  M R Young; J L Kut; M P Coogan; M A Wright; M E Young; J Matthews
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

7.  Effects of glucocorticoids on 5-HT1A presynaptic function in the mouse.

Authors:  A H Young; G M Goodwin; H Dick; G Fink
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

Review 8.  Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models.

Authors:  Angela J Grippo; Alan Kim Johnson
Journal:  Stress       Date:  2009-01       Impact factor: 3.493

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.